61 related articles for article (PubMed ID: 6872376)
1. [Superoxide dismutase activities in multi-system degeneration and parkinsonism].
Mizuno Y; Joshita Y
Rinsho Shinkeigaku; 1983 Mar; 23(3):203-11. PubMed ID: 6872376
[No Abstract] [Full Text] [Related]
2. Selegiline and lymphocyte superoxide dismutase activities in Parkinson's disease.
Kushleika J; Checkoway H; Woods JS; Moon JD; Smith-Weller T; Franklin GM; Swanson PD
Ann Neurol; 1996 Mar; 39(3):378-81. PubMed ID: 8602757
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopaminergic drugs on superoxide dismutase: implications for senescence.
Glover V; Clow A; Sandler M
J Neural Transm Suppl; 1993; 40():37-45. PubMed ID: 8294899
[TBL] [Abstract][Full Text] [Related]
4. Superoxide dismutase activity in early and advanced Parkinson's disease.
Bostantjopoulou S; Kyriazis G; Katsarou Z; Kiosseoglou G; Kazis A; Mentenopoulos G
Funct Neurol; 1997; 12(2):63-8. PubMed ID: 9238339
[TBL] [Abstract][Full Text] [Related]
5. Superoxide dismutase expression in Parkinson's disease.
Poirier J; Dea D; Baccichet A; Thiffault C
Ann N Y Acad Sci; 1994 Nov; 738():116-20. PubMed ID: 7832421
[No Abstract] [Full Text] [Related]
6. Superoxide dismutase activity in the nervous system.
Fried R
J Neurosci Res; 1979; 4(5-6):435-41. PubMed ID: 522198
[No Abstract] [Full Text] [Related]
7. [Studies on the pathogenesis of degenerative neurological disorders].
Mizuno Y
Rinsho Shinkeigaku; 1984 Feb; 24(2):118-24. PubMed ID: 6744744
[No Abstract] [Full Text] [Related]
8. Copper/zinc superoxide dismutase expression in the human central nervous system. Correlation with selective neuronal vulnerability.
Bergeron C; Petrunka C; Weyer L
Am J Pathol; 1996 Jan; 148(1):273-9. PubMed ID: 8546216
[TBL] [Abstract][Full Text] [Related]
9. Nitration of manganese superoxide dismutase in cerebrospinal fluids is a marker for peroxynitrite-mediated oxidative stress in neurodegenerative diseases.
Aoyama K; Matsubara K; Fujikawa Y; Nagahiro Y; Shimizu K; Umegae N; Hayase N; Shiono H; Kobayashi S
Ann Neurol; 2000 Apr; 47(4):524-7. PubMed ID: 10762167
[TBL] [Abstract][Full Text] [Related]
10. Brain superoxide dismutase, catalase, and glutathione peroxidase activities in amyotrophic lateral sclerosis.
Przedborski S; Donaldson D; Jakowec M; Kish SJ; Guttman M; Rosoklija G; Hays AP
Ann Neurol; 1996 Feb; 39(2):158-65. PubMed ID: 8967746
[TBL] [Abstract][Full Text] [Related]
11. Erythrocyte superoxide dismutase activity differs in clinical subgroups of Parkinson's disease patients.
Akbostanci MC; Kocatürk PA; Tan FU; Kavas GO
Acta Neurol Belg; 2001 Sep; 101(3):180-3. PubMed ID: 11817268
[TBL] [Abstract][Full Text] [Related]
12. Manganese superoxide dismutase expression in human central nervous system tumors.
Cobbs CS; Levi DS; Aldape K; Israel MA
Cancer Res; 1996 Jul; 56(14):3192-5. PubMed ID: 8764104
[TBL] [Abstract][Full Text] [Related]
13. Superoxide dismutase--applications and relevance to human diseases.
Noor R; Mittal S; Iqbal J
Med Sci Monit; 2002 Sep; 8(9):RA210-5. PubMed ID: 12218958
[TBL] [Abstract][Full Text] [Related]
14. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury.
Bayir H; Kagan VE; Clark RS; Janesko-Feldman K; Rafikov R; Huang Z; Zhang X; Vagni V; Billiar TR; Kochanek PM
J Neurochem; 2007 Apr; 101(1):168-81. PubMed ID: 17394464
[TBL] [Abstract][Full Text] [Related]
15. [Pathogenesis of Parkinson's disease: a possibility of oxidation].
Jiménez-Jiménez FJ; Molina JA; Fernández-Calle P; Cabrera-Valdivia F
Neurologia; 1993 Apr; 8(4):138-46. PubMed ID: 8517962
[No Abstract] [Full Text] [Related]
16. Genetic polymorphisms in Parkinson's disease.
Checkoway H; Farin FM; Costa-Mallen P; Kirchner SC; Costa LG
Neurotoxicology; 1998; 19(4-5):635-43. PubMed ID: 9745923
[TBL] [Abstract][Full Text] [Related]
17. Familial amyotrophic lateral sclerosis with a two base pair deletion in superoxide dismutase 1: gene multisystem degeneration with intracytoplasmic hyaline inclusions in astrocytes.
Kato S; Shimoda M; Watanabe Y; Nakashima K; Takahashi K; Ohama E
J Neuropathol Exp Neurol; 1996 Oct; 55(10):1089-101. PubMed ID: 8858006
[TBL] [Abstract][Full Text] [Related]
18. Brain proteasomal function in sporadic Parkinson's disease and related disorders.
Furukawa Y; Vigouroux S; Wong H; Guttman M; Rajput AH; Ang L; Briand M; Kish SJ; Briand Y
Ann Neurol; 2002 Jun; 51(6):779-82. PubMed ID: 12112087
[TBL] [Abstract][Full Text] [Related]
19. Remarkably suppressed manganese superoxide dismutase activity in malignant pheochromocytoma.
Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
J Urol; 1995 Jun; 153(6):1787-90. PubMed ID: 7752317
[TBL] [Abstract][Full Text] [Related]
20. Superficial siderosis of the central nervous system associated with parkinsonism.
Rieder CR; dos Santos Souza MP; de Freitas RM; Fricke D
Parkinsonism Relat Disord; 2004 Oct; 10(7):443-5. PubMed ID: 15465404
[No Abstract] [Full Text] [Related]
[Next] [New Search]
